Understanding healthcare communication in age-related macular degeneration care: A mixed-methods review of patients’ perspectivesShow others and affiliations
2024 (English)In: Survey of ophthalmology, ISSN 0039-6257, E-ISSN 1879-3304, Vol. 69, no 4, p. 646-660Article, review/survey (Refereed) Epub ahead of print
Abstract [en]
Age-related macular degeneration (AMD) is the most common cause of irreversible visual impairment among people aged 50 years and older. Earlier research has indicated that the communication process between patients and healthcare professionals (HCPs) leaves considerable room for improvement in AMD care. Effective communication is essential to enhance trust in the professional and understanding of the diagnosis and treatment, and decrease anxiety and stress related to illness. We review patients’ experiences, needs and preferences regarding information provision, communication style of the HCP and shared decision-making. We conducted a systematic search in PubMed, Embase, PsycINFO, CINAHL and Web of Science. Study quality was assessed using standard checklists of quality measures. Our search returned 31 eligible articles. Findings indicated current deficits in information provision for people with AMD. Patients were often ill-informed regarding the chronic character of the condition, treatment duration, nutrition, and visual aids and low vision rehabilitation. Many patients were not actively involved during the decision-making process. Altogether, patients with AMD are faced with challenges in terms of patient-HCP communication. Methods of providing information and discussing possible options for care need to be further investigated and improved for this patient group.
Place, publisher, year, edition, pages
2024. Vol. 69, no 4, p. 646-660
Keywords [en]
age-related macular degeneration, information provision, communication, shared, decision-making, systematic review
National Category
Nursing
Research subject
The Human Perspective in Care
Identifiers
URN: urn:nbn:se:hb:diva-31712DOI: 10.1016/j.survophthal.2024.03.002ISI: 001257628700001Scopus ID: 2-s2.0-85189946116OAI: oai:DiVA.org:hb-31712DiVA, id: diva2:1846323
2024-03-222024-03-222024-10-01Bibliographically approved